Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001039643 | SCV001203180 | uncertain significance | not provided | 2023-08-30 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs193110720, gnomAD 0.2%). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 85 of the TBXAS1 protein (p.Arg85Leu). This variant has not been reported in the literature in individuals affected with TBXAS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 838155). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001335602 | SCV001528785 | uncertain significance | Thromboxane synthetase deficiency | 2018-02-09 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |